Valuation: Proteome Sciences plc

Market Cap 57.87L 77.34L 67.58L 62.05L 1.1Cr 74Cr 1.12Cr 7.47Cr 2.9Cr 36Cr 2.9Cr 2.84Cr 124.43Cr P/E 2024
-2.95x
P/E 2025 -2.4x
Enterprise Value 2.08Cr 2.78Cr 2.43Cr 2.23Cr 3.94Cr 264.32Cr 4.01Cr 27Cr 10Cr 129.65Cr 10Cr 10Cr 446.73Cr EV / Sales 2024
4.79x
EV / Sales 2025 5.96x
Free-Float
81.91%
Yield 2024 *
-
Yield 2025 -
1 day+1.82%
1 week-2.04%
Current month+1.82%
1 month+5.00%
3 months+6.33%
6 months-37.78%
Current year-32.80%
1 week 1.3
Extreme 1.3
2.3
1 month 1.3
Extreme 1.3
2.3
Current year 1.2
Extreme 1.2
4.4
1 year 1.2
Extreme 1.2
4.4
3 years 1.2
Extreme 1.2
8.71
5 years 1.2
Extreme 1.2
8.79
10 years 1.2
Extreme 1.2
20.25
Manager TitleAgeSince
Corporate Officer/Principal - 01/04/2017
Corporate Secretary - 01/08/2017
Director TitleAgeSince
Chairman 73 30/06/2014
Director/Board Member 62 01/01/2010
Director/Board Member 71 01/07/2014
Date Insider Type Main position Quantity % Market Cap.
14/23/14
Vulpes Investment Management Pte Ltd.
BuyCompany 1,00,000 0.0339%
14/23/14
Vulpes Investment Management Pte Ltd.
BuyCompany 1,00,000 0.0339%
06/23/06
Vulpes Investment Management Pte Ltd.
BuyCompany 1,00,000 0.0339%
Change 5-day change 1-year change 3-year change Capi.($)
+17.19%-2.04%-44.74%-78.39% 77.34L
+3.49%+2.32%-28.86%-12.49% 17TCr
+5.04%+3.32%-5.77%-5.57% 11TCr
+2.80%+3.33%+1.83%+54.09% 5.77TCr
+1.33%+1.39%+53.16%+49.84% 5.32TCr
+3.39%+4.43%-10.83%-40.12% 4.36TCr
+3.50%+14.35% - - 3.65TCr
+3.47%+3.79%-14.75%-44.56% 2.75TCr
+0.20%+5.53%+65.33%-4.37% 2.58TCr
+2.78%+3.61%-8.42%-3.01% 2.13TCr
Average +2.78%+3.49%+0.77%-9.40% 5.38TCr
Weighted average by Cap. +3.31%+3.29%-3.68%-0.10%

Financials

2024 2025
Net sales 48.87L 65.31L 57.07L 52.4L 92.65L 62Cr 94.21L 6.31Cr 2.45Cr 30Cr 2.45Cr 2.4Cr 105.08Cr 37.56L 50.2L 43.86L 40.28L 71.2L 48Cr 72.41L 4.85Cr 1.88Cr 23Cr 1.88Cr 1.84Cr 81Cr
Net income -34.06L -45.52L -39.77L -36.52L -64.57L -43Cr -65.66L -4.4Cr -1.7Cr -21Cr -1.71Cr -1.67Cr -73Cr -30.61L -40.91L -35.74L -32.82L -58.03L -39Cr -59.01L -3.95Cr -1.53Cr -19Cr -1.54Cr -1.5Cr -66Cr
Net Debt 1.34Cr 1.79Cr 1.56Cr 1.44Cr 2.54Cr 170.41Cr 2.58Cr 17Cr 6.7Cr 84Cr 6.72Cr 6.57Cr 288Cr 1.5Cr 2Cr 1.75Cr 1.61Cr 2.84Cr 190.7Cr 2.89Cr 19Cr 7.5Cr 94Cr 7.52Cr 7.36Cr 322.3Cr
Logo Proteome Sciences plc
Proteome Sciences plc is a specialist provider of contract proteomics services. The Company’s services enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids. Its principal activities involve protein biomarker research and development. It uses high-sensitivity techniques to detect and characterize differentially expressed proteins in biological samples for diagnostic, prognostic and therapeutic applications. SysQuant and TMT MS2 are unbiased methods for identifying and contextualizing new targets and defining mechanisms of biological activity, while analysis using Super-Depletion and TMTcalibrator provides access to over 8,500 circulating plasma proteins for the discovery of disease-related biomarkers. In addition, it has invented and developed the technology for TMT and TMTpro, and manufactures these small, protein-reactive chemical reagents for multiplex quantitative proteomics.
Employees
32
Date Price Change Volume
03/26/03 GBX 1.934 +17.19% 1,18,861
02/26/02 GBX 1.650 0.00% 2
01/26/01 GBX 1.650 0.00% 29,546
30/26/30 GBX 1.650 -8.33% 54,141
29/26/29 GBX 1.800 +4.96% 4,86,345